$32.17
+0.31 (+0.97%)
Open$31.51
Previous Close$31.86
Day High$33.00
Day Low$31.32
52W High$44.60
52W Low$13.50
Volume—
Avg Volume619.8K
Market Cap1.98B
P/E Ratio—
EPS$-8.45
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
-8.3% upside
Current
$32.17
$32.17
Target
$29.51
$29.51
$22.12
$29.51 avg
$35.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.79M | 140.52M | 130.81M |
| Net Income | -520,719,073 | -116,113 | -126,311 |
| Profit Margin | -3,777.4% | -0.1% | -0.1% |
| EBITDA | -527,976,632 | -178,287 | -168,053 |
| Free Cash Flow | — | -139,366 | -118,293 |
| Rev Growth | — | -3.7% | +16.0% |
| Debt/Equity | 0.32 | 0.89 | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |